Breaking the mold: asciminib as a standard-of-care of the therapeutic armamentarium of chronic myeloid leukemia in the upfront setting
Yllmaz R., EŞKAZAN A. E.
Future Oncology, vol.19, no.8, pp.545-547, 2023 (SCI-Expanded)
-
Publication Type:
Article / Editorial Material
-
Volume:
19
Issue:
8
-
Publication Date:
2023
-
Doi Number:
10.2217/fon-2023-0095
-
Journal Name:
Future Oncology
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
-
Page Numbers:
pp.545-547
-
Keywords:
ASC4FIRST, asciminib, chronic myeloid leukemia, STAMP, TKI, tyrosine kinase inhibitor
-
Istanbul University Affiliated:
Yes